138 related articles for article (PubMed ID: 18260163)
1. Granulomatous hepatitis associated with etanercept therapy.
Farah M; Al Rashidi A; Owen DA; Yoshida EM; Reid GD
J Rheumatol; 2008 Feb; 35(2):349-51. PubMed ID: 18260163
[TBL] [Abstract][Full Text] [Related]
2. Development of sarcoidosis during etanercept therapy.
Ishiguro T; Takayanagi N; Kurashima K; Matsushita A; Harasawa K; Yoneda K; Tsuchiya N; Miyahara Y; Yamaguchi S; Yano R; Tokunaga D; Saito H; Ubukata M; Yanagisawa T; Sugita Y; Kawabata Y
Intern Med; 2008; 47(11):1021-5. PubMed ID: 18520114
[TBL] [Abstract][Full Text] [Related]
3. Surgery in rheumatoid arthritis patients under anti-TNF-alpha therapy: what is the risk?
Wendling D
Clin Rheumatol; 2007 Aug; 26(8):1396-7. PubMed ID: 17318273
[No Abstract] [Full Text] [Related]
4. Septic arthritis of the right ankle caused by Staphylococcus aureus infection in a rheumatoid arthritis patient treated with etanercept.
Waguri-Nagaya Y; Kobayashi M; Goto H; Hisazaki S; Tsuchiya A; Otsuka T
Mod Rheumatol; 2007; 17(4):338-40. PubMed ID: 17694271
[TBL] [Abstract][Full Text] [Related]
5. Sensory-motor axonal multineuropathy during etanercept therapy for rheumatoid arthritis.
De Stefano R; Frati E; Volpi N; Galeazzi M
Clin Exp Rheumatol; 2009; 27(2):381. PubMed ID: 19473586
[No Abstract] [Full Text] [Related]
6. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept.
Bagalas V; Kioumis I; Argyropoulou P; Patakas D
Clin Rheumatol; 2007 Aug; 26(8):1344-5. PubMed ID: 16865310
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
8. Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
Yokoyama W; Takada K; Miyasaka N; Kohsaka H
BMJ Case Rep; 2014 Aug; 2014():bcr-2014-205779. PubMed ID: 25085953
[TBL] [Abstract][Full Text] [Related]
9. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced systemic lupus erythematosus associated with etanercept therapy.
Shakoor N; Michalska M; Harris CA; Block JA
Lancet; 2002 Feb; 359(9306):579-80. PubMed ID: 11867114
[TBL] [Abstract][Full Text] [Related]
11. Etanercept-induced granulomatous hepatitis as a rare cause of abnormal liver tests.
Peixoto A; Martins Rocha T; Santos-Antunes J; Aguiar F; Bernardes M; Vaz C; Pereira P; Macedo G
Acta Gastroenterol Belg; 2019; 82(1):93-95. PubMed ID: 30888761
[TBL] [Abstract][Full Text] [Related]
12. Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment.
Vassilopoulos D; Sialevris K; Malahtari S; Deutsch M; Manolakopoulos S; Archimandritis AJ
J Clin Rheumatol; 2010 Mar; 16(2):88-9. PubMed ID: 20216130
[No Abstract] [Full Text] [Related]
13. Granulomatous lung disease occurring during etanercept treatment.
Phillips K; Weinblatt M
Arthritis Rheum; 2005 Aug; 53(4):618-20. PubMed ID: 16082636
[No Abstract] [Full Text] [Related]
14. Developing of granulomatous thyroiditis during etanercept therapy.
Cañas CA; Tobón GJ; Arango LG; Guarín N
Clin Rheumatol; 2009 Jun; 28 Suppl 1():S17-9. PubMed ID: 19043773
[TBL] [Abstract][Full Text] [Related]
15. Liver toxicity of TNFalpha antagonists.
Dominique L
Joint Bone Spine; 2008 Dec; 75(6):636-8. PubMed ID: 18952478
[No Abstract] [Full Text] [Related]
16. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
Broshtilova V; Iliev E; Gantcheva M
Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
[TBL] [Abstract][Full Text] [Related]
17. New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
Song IH; Appel H; Haibel H; Loddenkemper C; Braun J; Sieper J; Rudwaleit M
J Rheumatol; 2008 Mar; 35(3):532-6. PubMed ID: 18203308
[TBL] [Abstract][Full Text] [Related]
18. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with very low-dose etanercept in a patient with etanercept-induced liver dysfunction.
Iwamoto M; Minota S
Rheumatol Int; 2011 Apr; 31(4):561-2. PubMed ID: 20349067
[No Abstract] [Full Text] [Related]
20. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.
Toussirot E; Berthelot JM; Pertuiset E; Bouvard B; Gaudin P; Wendling D; le Noach J; Lohse A; Lecuyer E; Cri L
J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
